03.01.2015 Views

The Indian Journal of Tuberculosis - LRS Institute of Tuberculosis ...

The Indian Journal of Tuberculosis - LRS Institute of Tuberculosis ...

The Indian Journal of Tuberculosis - LRS Institute of Tuberculosis ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

LASER THERAPY IN TUBERCULOSIS 137<br />

group and 61 were kept as control group. Male to<br />

female ratio was 1.71:1. Mean age <strong>of</strong> patient was 30.78<br />

(Table 1), mean duration <strong>of</strong> illness before receiving<br />

therapy was 3.19 yrs. (Table 2). <strong>The</strong> most common<br />

drug resistance was found to be <strong>of</strong> Isoniazid ,<br />

followed by Pyrazinamide, Streptomycin and<br />

Rifampicin. In our study least resistant was found<br />

to be <strong>of</strong> Quinolone group (Cipr<strong>of</strong>loxacin ) (Figure-1).<br />

No. <strong>of</strong> patients<br />

70<br />

60<br />

50<br />

40<br />

30<br />

20<br />

10<br />

64<br />

48<br />

8<br />

16<br />

34<br />

62<br />

47<br />

13<br />

H : INH<br />

S : Streptomycin<br />

Pa : PAS<br />

T : Thiacetazone<br />

E : Ethambutol<br />

Z : Pyrazinamide<br />

R : Rifampicin<br />

K : Kanamycin<br />

Et : Ethionamide<br />

C : Cipr<strong>of</strong>loxacin<br />

28<br />

6<br />

0<br />

H S Pa T E Z R K Et C<br />

Resistant to<br />

Fig: Pattern <strong>of</strong> drug resistance according to culture sensitivity report<br />

Table 1: Age wise distribution <strong>of</strong> cases<br />

among LLLT Group and Control<br />

Group<br />

Age LLT Group Control Group<br />

(in yrs.) No. % No. %<br />

15-25 20 32.78 21 34.42<br />

26-35 26 42.62 23 37.70<br />

36-45 11 18.03 11 18.03<br />

46-55 3 4.91 6 9.83<br />

56-65 1 1.63 0 0<br />

Total 61 100 61 100<br />

(z test, z=0.09; p> 0.10; Insignificant)<br />

Table 2: Duration <strong>of</strong> illness before receiving<br />

treatment among LLLT Group and<br />

Control Group<br />

Duration LLT Group Control Group<br />

(in months) No. % No. %<br />

12-24 29 47.54 37 60.65<br />

25-36 15 24.59 7 11.47<br />

37-48 3 4.91 6 9.83<br />

49-60 5 8.19 5 8.19<br />

> 5 yrs 9 14.75 6 9.83<br />

Total 61 100<br />

(z test, z=1.45; p> 0.05; Insignificant)<br />

61 100<br />

<strong>Indian</strong> <strong>Journal</strong> <strong>of</strong> <strong>Tuberculosis</strong>

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!